Showing results (21-30 of 83) with videos related to
Sort By:
Pageof 9
Epigenetics & Chromatin|March 7, 2025
Impact of chromatin on HIV-1 latency: a multi-dimensional perspectiveJoanna E Jones, Chelsea E Gunderson, Brian Wigdahl, et al.Viruses|March 28, 2026
Breaking into HIV-1's Epigenetic Vault: Cure Strategies to Eliminate the Viral ReservoirJoanna E Jones, Chelsea E Gunderson, Brian Wigdahl, et al.Plos One|February 20, 2014
CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineageSatinder Dahiya, Yujie Liu, Michael R Nonnemacher, et al.Advances in Virus Research|June 27, 2015
Human Immunodeficiency Virus Type 1 Cellular Entry and Exit in the T Lymphocytic and Monocytic Compartments: Mechanisms and Target Opportunities During Viral DiseaseBenjamas Aiamkitsumrit, Neil T Sullivan, Michael R Nonnemacher, et al.Journal of Neuroimmunology|December 8, 2004
Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progressionMichael R Nonnemacher, Bryan P Irish, Yujie Liu, et al.Journal of Neuroscience Methods|May 25, 2016
Co-culture model consisting of human brain microvascular endothelial and peripheral blood mononuclear cellsMarianne Strazza, Monique E Maubert, Vanessa Pirrone, et al.Virology Journal|June 3, 2014
Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site ISonia Shah, Aikaterini Alexaki, Vanessa Pirrone, et al.Molecular Neurobiology|March 22, 2024
Acute Administration of HIV-1 Tat Protein Drives Glutamatergic Alterations in a Rodent Model of HIV-Associated Neurocognitive DisordersBrenna C Duffy, Kirsten M King, Binod Nepal, et al.MOJ Immunology|April 21, 2015
HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a CureWill Dampier, Michael R Nonnemacher, Neil T Sullivan, et al.Journal of Neurovirology|July 8, 2011
Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesisAnupam Banerjee, Marianne Strazza, Brian Wigdahl, et al.Pageof 9